Results 201 to 210 of about 96,458 (298)

Aortic regurgitation and combined ventricular tachycardia due to IgG4-related disease. [PDF]

J Cardiothorac Surg
Hyun S, Lee S, Kim DJ, Hong YS, Lim SH, Park SJ.   +5 more
europepmc   +1 more source

Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease

Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.
Reduces cardiac remodelling and apoptosis in dogs with MMVD stage B2: Long‐term treatment with ivabradine in dogs with asymptomatic myxomatous mitral valve disease (MMVD) stage B2 reduced heart rate without impairing cardiac function. ABSTRACT Background Ivabradine, a specific funny channel blocker, has shown cardiovascular benefits in humans and ...
Prapawadee Pirintr, Vudhiporn Limprasutr, Anudep Rungsipipat, Kasem Rattanapinyopituk, Suwanakiet Sawangkoon, Nakkawee Saengklub, Anusak Kijtawornrat   +6 more
wiley   +1 more source

Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy [PDF]

, 2016
Borgeat, K A, Brodbelt, D C, Connolly, D J, Fuentes, V L, Payne, J R   +4 more
core   +1 more source

Severe aortic regurgitation with acute decompensation as initial presentation of Behçet's syndrome: a case report. [PDF]

Eur Heart J Case Rep
Mansour S, Dimov I, Rietz M, Beun AJ, Unger P.   +4 more
europepmc   +1 more source

Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. [PDF]

, 1980
Walter L. Henry, Robert O. Bonow, Douglas R. Rosing, Stephen E. Epstein   +3 more
openalex   +1 more source

Safety and Efficacy of Aveir Leadless Pacemaker in Chinese Patients

Annals of Noninvasive Electrocardiology, Volume 31, Issue 1, January 2026.
The application of Aveir, as a newly approved leadless pacemaker (LP), in the Chinese population remains limited. This retrospective study aimed to evaluate the safety and efficacy of the Aveir LP in Chinese patients. ABSTRACT Background Aveir, as a newly approved leadless pacemaker (LP), has been increasingly adopted in clinical practice. However, its
Wuyang Zheng, Ziguan Zhang, Zuheng Liu, Yuxiao Ma, Changqing Sun, Wangwei He, Yan Ge, Xiongbiao Lin, Yueming Wu, Qiang Xie   +9 more
wiley   +1 more source

Cardiac Damage in Aortic Regurgitation: Refining Risk Beyond Valve Severity. [PDF]

Struct Heart
Avvedimento M.
europepmc   +1 more source

Postinterventional fetal aortic regurgitation: prevalence, outcome and effects on fetal circulation in large single‐center cohort [PDF]

Andreas Tulzer, Julian Hochpoechler, Iris Scharnreitner, Viktor Tomek, Roland Weber, Eva Sames-Dolzer, Michaela Kreuzer, Rudolf Mair, Rudolf Mair, Gerald Tulzer   +9 more
openalex   +1 more source

Age‐related differences in cardiogenic shock secondary to Takotsubo syndrome

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
In this multicenter study of 408 patients with cardiogenic shock secondary to Takotsubo syndrome (CS‐TTS), age emerged as a major determinant of clinical profile and prognosis, along with SCAI shock stage. Younger patients presented with more atypical features and received more intensive support but had better short‐ and long‐term outcomes.
Marco Tomasino, Ravi Vazirani, Jorge Salamanca, Sergio Raposeiras‐Roubin, Clara Fernández‐Cordón, Miguel Corbí‐Pascual, Oscar Vedia, Agustín C. Martín‐García, Emilia Blanco‐Ponce, Manuel Almendro Delia, Alberto Piserra‐López, Jaime Francisco Larre Guerra, Francisco Gonzalez‐Santorum, Carmen Lluch‐Requerey, Marta Guillén‐Marzo, Alberto Pérez‐Castellanos, Francisco Ridocci‐Soriano, Javier Lopez‐País, Rut Andrea, Alessandro Sionis, Iván J. Núñez‐Gil, Aitor Uribarri   +21 more
wiley   +1 more source

Quadricuspid Aortic Valve With Severe Aortic Regurgitation. [PDF]

Clin Case Rep
Minatoya T, Hayashi A, Okamoto H, Asada K, Takashima N, Suzuki T, Nakagawa Y.   +6 more
europepmc   +1 more source